HOUSTON & LEIDEN, The Netherlands--(BUSINESS WIRE)--Stem Cell Innovations, Inc. (OTCBB: SCLL) announced today that the Company and TNO will collaborate in a program sponsored by a Dutch government EZ-Co-financing grant. The Parties have developed and will explore new strategies to control human stem cell differentiation into cartilage and cardiomyocytes.
